Non-coding RNAs regulating endothelial progenitor cells for venous thrombosis: promising therapy and innovation

[1]  J. Qin,et al.  LINC00659 exacerbates endothelial progenitor cell dysfunction in deep vein thrombosis of the lower extremities by activating DNMT3A-mediated FGF1 promoter methylation , 2023, Thrombosis Journal.

[2]  Yiqi Jin,et al.  Downregulation of miR-125a-5p Promotes Endothelial Progenitor Cell Migration and Angiogenesis and Alleviates Deep Vein Thrombosis in Mice Via Upregulation of MCL-1 , 2023, Molecular Biotechnology.

[3]  Xiao-Qiu Wang,et al.  A novel circ_0018553 protects against angiotensin-induced cardiac hypertrophy in cardiomyocytes by modulating the miR-4731/SIRT2 signaling pathway , 2022, Hypertension Research.

[4]  W. Chilian,et al.  Endothelial progenitor cells in the host defense response. , 2022, Pharmacology & therapeutics.

[5]  Xiao-yun Luo,et al.  MicroRNA-136-5p from Endothelial Progenitor Cells-released Extracellular Vesicles Mediates TXNIP to Promote the Dissolution of Deep Venous Thrombosis , 2022, Shock.

[6]  Y. Devaux,et al.  Noncoding RNAs in age-related cardiovascular diseases , 2022, Ageing Research Reviews.

[7]  J. Ge,et al.  Upregulated miR-206 Aggravates Deep Vein Thrombosis by Regulating GJA1-Mediated Autophagy of Endothelial Progenitor Cells , 2022, Cardiovascular therapeutics.

[8]  Fan Zhang,et al.  Hsa_circ_0001020 accelerates the lower extremity deep vein thrombosis via sponging miR-29c-3p to promote MDM2 expression. , 2022, Thrombosis research.

[9]  W. Song,et al.  Up-regulated miR-204-5p promoted the migration, invasion, and angiogenesis of endothelial progenitor cells to enhance the thrombolysis of rats with deep venous thrombosis by targeting SPRED1. , 2021, Experimental cell research.

[10]  Ying Deng,et al.  Integrated analysis of long non-coding RNA-microRNA-mRNA competing endogenous RNAregulatory networks in thromboangiitis obliterans , 2021, Bioengineered.

[11]  S. Kahn,et al.  Post‐thrombotic syndrome in patients with venous thromboembolism treated with dabigatran or warfarin: A long‐term cross‐sectional follow‐up of RE‐COVER study patients , 2021, Journal of thrombosis and haemostasis : JTH.

[12]  N. Rezaei,et al.  Long Non-Coding RNAs in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-of-the-Art Review , 2021, Frontiers in Oncology.

[13]  Kaiyuan Niu,et al.  Pathological Bases and Clinical Application of Long Noncoding RNAs in Cardiovascular Diseases. , 2021, Hypertension.

[14]  Z. Zeng,et al.  The influence of circular RNAs on autophagy and disease progression , 2021, Autophagy.

[15]  L. Mazzolai,et al.  Post-thrombotic syndrome - a position paper from European Society of Vascular Medicine. , 2021, VASA. Zeitschrift fur Gefasskrankheiten.

[16]  Fan Zhang,et al.  LncRNA Sirt1-AS upregulates Sirt1 to attenuate aging related deep venous thrombosis , 2021, Aging.

[17]  B. Kumar,et al.  Transcriptome Profiling Reveals the Endogenous Sponging Role of LINC00659 and UST-AS1 in High-Altitude Induced Thrombosis , 2021, Thrombosis and Haemostasis.

[18]  M. Taheri,et al.  Exploring the role of non-coding RNAs in autophagy , 2021, Autophagy.

[19]  R. Chopard,et al.  Diagnosis and Treatment of Lower Extremity Venous Thromboembolism: A Review. , 2020, JAMA.

[20]  Jian Zhu,et al.  Clarification of the Role of miR-9 in the Angiogenesis, Migration, and Autophagy of Endothelial Progenitor Cells Through RNA Sequence Analysis , 2020, Cell transplantation.

[21]  K. Jeevaratnam,et al.  Circulating microRNA as a Biomarker for Coronary Artery Disease , 2020, Biomolecules.

[22]  P. Sandset,et al.  Predictors of long-term post-thrombotic syndrome following high proximal deep vein thrombosis: a cross-sectional study , 2020, Thrombosis Journal.

[23]  Lun Xiao,et al.  LncRNA GUSBP5-AS promotes EPC migration and angiogenesis and deep vein thrombosis resolution by regulating FGF2 and MMP2/9 through the miR-223-3p/FOXO1/Akt pathway , 2020, Aging.

[24]  Jian Zhu,et al.  MiR‐9 promotes angiogenesis of endothelial progenitor cell to facilitate thrombi recanalization via targeting TRPM7 through PI3K/Akt/autophagy pathway , 2020, Journal of cellular and molecular medicine.

[25]  B. Kumar,et al.  MicroRNAs in Venous Thrombo-Embolism. , 2020, Clinica chimica acta; international journal of clinical chemistry.

[26]  J. Weitz,et al.  Novel Antithrombotic Strategies for Treatment of Venous Thromboembolism. , 2020, Blood.

[27]  S. Kahn,et al.  Long-term treatment of venous thromboembolism. , 2020, Blood.

[28]  R. Zeng,et al.  LncRNA ANRIL promotes angiogenesis and thrombosis by modulating microRNA-99a and microRNA-449a in the autophagy pathway. , 2019, American journal of translational research.

[29]  Ziyuan Guo,et al.  Mechanisms of lncRNA/microRNA interactions in angiogenesis. , 2019, Life sciences.

[30]  Caixia Wang,et al.  Elevated miR-195-5p expression in deep vein thrombosis and mechanism of action in the regulation of vascular endothelial cell physiology , 2019, Experimental and therapeutic medicine.

[31]  Lun Xiao,et al.  MiR‐205 promotes endothelial progenitor cell angiogenesis and deep vein thrombosis recanalization and resolution by targeting PTEN to regulate Akt/autophagy pathway and MMP2 expression , 2019, Journal of cellular and molecular medicine.

[32]  Yanqiu Zhou,et al.  LncRNA CAIF was downregulated in end-stage cardiomyopathy and is a promising diagnostic and prognostic marker for this disease , 2019, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[33]  Zhen Lu,et al.  Resveratrol Induces Endothelial Progenitor Cells Angiogenesis via MiR-542-3p by Targeting Angiopoietin-2 and Involves in Recanalization of Venous Thrombosis , 2019, Medical science monitor : international medical journal of experimental and clinical research.

[34]  Zhao Liu,et al.  Metformin inhibits angiogenesis of endothelial progenitor cells via miR-221-mediated p27 expression and autophagy. , 2019, Future medicinal chemistry.

[35]  Jian Sun,et al.  Resveratrol attenuates pulmonary embolism associated cardiac injury by suppressing activation of the inflammasome via the MALAT1‑miR‑22‑3p signaling pathway. , 2019, International journal of molecular medicine.

[36]  Q. Xiang,et al.  The predictive value of circulating microRNAs for venous thromboembolism diagnosis: A systematic review and diagnostic meta-analysis. , 2019, Thrombosis research.

[37]  Lili Sun,et al.  miR-21 induces endothelial progenitor cells proliferation and angiogenesis via targeting FASLG and is a potential prognostic marker in deep venous thrombosis , 2019, Journal of Translational Medicine.

[38]  Mulin Liu,et al.  MiR-150 promotes angiogensis and proliferation of endothelial progenitor cells in deep venous thrombosis by targeting SRCIN1. , 2019, Microvascular research.

[39]  Xuejun Jiang,et al.  The overexpression of lncRNA H19 as a diagnostic marker for coronary artery disease. , 2019, Revista da Associacao Medica Brasileira.

[40]  Lun Xiao,et al.  LncRNA WTAPP1 Promotes Migration and Angiogenesis of Endothelial Progenitor Cells via MMP1 Through MicroRNA 3120 and Akt/PI3K/Autophagy Pathways , 2018, Stem cells.

[41]  K. Lackner,et al.  Large‐scale identification of functional microRNA targeting reveals cooperative regulation of the hemostatic system , 2018, Journal of thrombosis and haemostasis : JTH.

[42]  T. Fukuda,et al.  Beneficial Effect of Endovascular Treatment on Villalta Score in Japanese Patients With Chronic Iliofemoral Venous Thrombosis and Post-Thrombotic Syndrome. , 2018, Circulation journal : official journal of the Japanese Circulation Society.

[43]  Summer S. Han,et al.  Intracranial Hemorrhage in Deep Vein Thrombosis/Pulmonary Embolus Patients Without Atrial Fibrillation: Direct Oral Anticoagulants Versus Warfarin , 2018, Stroke.

[44]  G. Boon,et al.  Management and treatment of deep vein thrombosis in special populations , 2018, Expert review of hematology.

[45]  X. Deng,et al.  Wedelolactone inhibits osteoclastogenesis but enhances osteoblastogenesis through altering different semaphorins production , 2018, International immunopharmacology.

[46]  Li-Li Sun,et al.  The regulatory role of microRNAs in angiogenesis‐related diseases , 2018, Journal of cellular and molecular medicine.

[47]  J. Horowitz,et al.  Epidemiology, Pathophysiology, and Natural History of Pulmonary Embolism , 2018, Seminars in Interventional Radiology.

[48]  B. Owens,et al.  Risk Factors for Deep Vein Thrombosis or Pulmonary Embolus Following Anterior Cruciate Ligament Reconstruction , 2018, Orthopaedic journal of sports medicine.

[49]  S. Kahn,et al.  How I treat the postthrombotic syndrome. , 2018, Blood.

[50]  Chaonan Wang,et al.  Percutaneous Endovenous Intervention Plus Anticoagulation versus Anticoagulation Alone for Treating Patients with Proximal Deep Vein Thrombosis: A Meta-analysis and Systematic Review. , 2018, Annals of vascular surgery.

[51]  Viorel Simion,et al.  LncRNAs in vascular biology and disease. , 2018, Vascular pharmacology.

[52]  C. Kabrhel,et al.  Epidemiology, Pathophysiology, Stratification, and Natural History of Pulmonary Embolism. , 2017, Techniques in vascular and interventional radiology.

[53]  C. Hölscher,et al.  Integrating microRNA and messenger RNA expression profiles in a rat model of deep vein thrombosis , 2017, International journal of molecular medicine.

[54]  T. Kondo,et al.  Detection of intrathrombotic endothelial progenitor cells and its application to thrombus age estimation in a murine deep vein thrombosis model , 2017, International Journal of Legal Medicine.

[55]  F. Klok,et al.  Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature , 2017, European Respiratory Journal.

[56]  J. Mo,et al.  MicroRNA-195 regulates proliferation, migration, angiogenesis and autophagy of endothelial progenitor cells by targeting GABARAPL1 , 2016, Bioscience reports.

[57]  Wen-Dong Li,et al.  Endothelial progenitor cells accelerate the resolution of deep vein thrombosis. , 2016, Vascular pharmacology.

[58]  E. Gamazon,et al.  Novel genetic predictors of venous thromboembolism risk in African Americans. , 2016, Blood.

[59]  M. Ballantyne,et al.  lncRNA/MicroRNA interactions in the vasculature , 2016, Clinical pharmacology and therapeutics.

[60]  J. Sundquist,et al.  Diagnostic potential of plasma microRNA signatures in patients with deep-vein thrombosis , 2016, Thrombosis and Haemostasis.

[61]  H. Zhuang,et al.  Upregulation of miR-483-3p contributes to endothelial progenitor cells dysfunction in deep vein thrombosis patients via SRF , 2016, Journal of Translational Medicine.

[62]  J. Heit,et al.  The epidemiology of venous thromboembolism , 2016, Journal of Thrombosis and Thrombolysis.

[63]  Howard Y. Chang,et al.  Unique features of long non-coding RNA biogenesis and function , 2015, Nature Reviews Genetics.

[64]  Wenbin Wang,et al.  Upregulation of MicroRNA‐126 Contributes to Endothelial Progenitor Cell Function in Deep Vein Thrombosis via Its Target PIK3R2 , 2015, Journal of cellular biochemistry.

[65]  G. Martin,et al.  AGE AND HUMAN REGENERATIVE CAPACITY: IMPACT OF CARDIOVASCULAR RISK FACTORS , 2015 .

[66]  P. Su,et al.  Aberrant expression of long noncoding RNAs in chronic thromboembolic pulmonary hypertension , 2014, Molecular medicine reports.

[67]  Peilong Li,et al.  The Long Noncoding RNA CHRF Regulates Cardiac Hypertrophy by Targeting miR-489 , 2014, Circulation research.

[68]  E. V. de Paula,et al.  Circulating Progenitor and Mature Endothelial Cells in Deep Vein Thrombosis , 2013, International journal of medical sciences.

[69]  A. Comerota,et al.  Embolization during treatment of deep venous thrombosis: incidence, importance, and prevention. , 2011, Techniques in vascular and interventional radiology.

[70]  J. Corral,et al.  Potential Role of miRNAs in Developmental Haemostasis , 2011, PloS one.

[71]  T. Wakefield,et al.  Do galectins play a role in venous thrombosis? a review. , 2010, Thrombosis research.

[72]  R. Gregory,et al.  Many roads to maturity: microRNA biogenesis pathways and their regulation , 2009, Nature Cell Biology.

[73]  I. Baumgartner,et al.  Cell-based therapy facilitates venous thrombus resolution , 2009, Thrombosis and Haemostasis.

[74]  O. Janssen,et al.  Posttranslational regulation of Fas ligand function , 2008, Cell Communication and Signaling.

[75]  L. Dimeglio,et al.  In Vitro Hyperglycemia or a Diabetic Intrauterine Environment Reduces Neonatal Endothelial Colony-Forming Cell Numbers and Function , 2008, Diabetes.

[76]  P. Jagodziński,et al.  Endothelial progenitor cells as a new agent contributing to vascular repair , 2007, Archivum Immunologiae et Therapiae Experimentalis.

[77]  M. Cushman.  Epidemiology and risk factors for venous thrombosis. , 2007, Seminars in hematology.

[78]  A. Rivard,et al.  Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities. , 2006, Atherosclerosis.

[79]  S. Goldhaber,et al.  Acute pulmonary embolism: part I: epidemiology and diagnosis. , 2006, Circulation.

[80]  R. Plasterk,et al.  Micro RNAs in Animal Development , 2006, Cell.

[81]  Z. Yang,et al.  Circulating endothelial progenitor cell deficiency contributes to impaired arterial elasticity in persons of advancing age , 2006, Journal of Human Hypertension.

[82]  G. Nickenig,et al.  Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy? , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[83]  B. Modarai,et al.  Endothelial Progenitor Cells Are Recruited Into Resolving Venous Thrombi , 2005, Circulation.

[84]  Alberto Smith,et al.  The role of neovascularisation in the resolution of venous thrombus , 2005, Thrombosis and Haemostasis.

[85]  A. Quyyumi,et al.  Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. , 2003, The New England journal of medicine.

[86]  B. Line.  Pathophysiology and diagnosis of deep venous thrombosis. , 2001, Seminars in nuclear medicine.

[87]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[88]  Paolo Prandoni,et al.  The Long-Term Clinical Course of Acute Deep Venous Thrombosis , 1996, Annals of Internal Medicine.

[89]  W. Chilian,et al.  Endothelial Progenitor Cells in the Host Defense Response , 2022, SSRN Electronic Journal.

[90]  Yigit Goktay,et al.  Endovascular Treatment of Thrombosis and Embolism. , 2017, Advances in experimental medicine and biology.

[91]  G. Raskob,et al.  The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs. , 2016, Thrombosis research.

[92]  Xiao-long Du,et al.  Long noncoding RNA expression profile of endothelial progenitor cells from deep vein thrombosis patients identified by microarray analysis , 2016 .

[93]  L. Melton,et al.  Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. , 2000, Archives of internal medicine.

[94]  T. Hyers,et al.  Venous thromboembolism. , 1999, American journal of respiratory and critical care medicine.